Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/2206
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMarshall, H.en
dc.contributor.authorBlyth, C. C.en
dc.contributor.authorClark, J. E.en
dc.contributor.authorCrawford, N.en
dc.contributor.authorJones, C. A.en
dc.contributor.authorBooy, R.en
dc.contributor.authorMacartney, K.en
dc.contributor.authorElliott, E. J.en
dc.contributor.authorBritton, P. N.en
dc.contributor.authorDale, R. C.en
dc.date.accessioned2022-11-07T23:29:07Z-
dc.date.available2022-11-07T23:29:07Z-
dc.date.issued2020en
dc.identifier.citation70, (12), 2020, p. 2517-2526en
dc.identifier.otherRISen
dc.identifier.urihttp://dora.health.qld.gov.au/qldresearchjspui/handle/1/2206-
dc.description.abstractBackground: We aimed to determine the contemporary causes, clinical features, and short-term outcome of encephalitis in Australian children. Methods. We prospectively identified children (≤14 years of age) admitted with suspected encephalitis at 5 major pediatric hospitals nationally between May 2013 and December 2016 using the Paediatric Active Enhanced Disease Surveillance (PAEDS) Network. A multidisciplinary expert panel reviewed cases and categorized them using published definitions. Confirmed encephalitis cases were categorized into etiologic subgroups. Results. From 526 cases of suspected encephalitis, 287 children met criteria for confirmed encephalitis: 57% (95% confidence interval [CI], 52%-63%) had infectious causes, 10% enterovirus, 10% parechovirus, 8% bacterial meningoencephalitis, 6% influenza, 6% herpes simplex virus (HSV), and 6% Mycoplasma pneumoniae; 25% (95% CI, 20%-30%) had immune-mediated encephalitis, 18% acute disseminated encephalomyelitis, and 6% anti-N-methyl-d-aspartate receptor encephalitis; and 17% (95% CI, 13%-21%) had an unknown cause. Infectious encephalitis occurred in younger children (median age, 1.7 years [interquartile range {IQR}, 0.1-6.9]) compared with immune-mediated encephalitis (median age, 7.6 years [IQR, 4.6-12.4]). Varicella zoster virus encephalitis was infrequent following high vaccination coverage since 2007. Thirteen children (5%) died: 11 with infectious causes (2 influenza; 2 human herpesvirus 6; 2 group B Streptococcus; 2 Streptococcus pneumoniae; 1 HSV; 1 parechovirus; 1 enterovirus) and 2 with no cause identified. Twenty-seven percent (95% CI, 21%-31%) of children showed moderate to severe neurological sequelae at discharge. Conclusions. Epidemic viral infections predominated as causes of childhood encephalitis in Australia. The leading causes include vaccine-preventable diseases. There were significant differences in age, clinical features, and outcome among leading causes. Mortality or short-term neurological morbidity occurred in one-third of cases.L20084378892020-11-17 <br />2020-12-23 <br />en
dc.language.isoenen
dc.relation.ispartofClinical Infectious Diseasesen
dc.titleCauses and clinical features of childhood encephalitis: A multicenter, prospective cohort studyen
dc.typeArticleen
dc.identifier.doi10.1093/cid/ciz685en
dc.subject.keywordsbacterial infectionen
dc.subject.keywordschilden
dc.subject.keywordschildhood diseaseen
dc.subject.keywordsclinical featureen
dc.subject.keywordsclinical outcomeen
dc.subject.keywordscohort analysisen
dc.subject.keywordsencephalitisen
dc.subject.keywordsEnterovirusen
dc.subject.keywordsfemaleen
dc.subject.keywordsHerpes simplex virusen
dc.subject.keywordsherpes zoster encephalitisen
dc.subject.keywordshospitalizationen
dc.subject.keywordshumanen
dc.subject.keywordsHuman herpesvirus 6en
dc.subject.keywordsHuman respiratory syncytial virusen
dc.subject.keywordsinfectious encephalitisen
dc.subject.keywordsinfluenzaen
dc.subject.keywordsanti NMDA receptor encephalitisen
dc.subject.keywordsmaleen
dc.subject.keywordsmeningoencephalitisen
dc.subject.keywordsMurray Valley encephalitis virusen
dc.subject.keywordsMycoplasma pneumoniaeen
dc.subject.keywordsnonhumanen
dc.subject.keywordsParechovirusen
dc.subject.keywordspriority journalen
dc.subject.keywordsStreptococcus agalactiaeen
dc.subject.keywordsStreptococcus pneumoniaeen
dc.subject.keywordsvaccination coverageen
dc.subject.keywordsvirus encephalitisen
dc.subject.keywordsadverse outcomeen
dc.subject.keywordsacute disseminated encephalomyelitisadolescenten
dc.subject.keywordsmajor clinical studyen
dc.subject.keywordsarticleen
dc.subject.keywordsAustraliaen
dc.relation.urlhttps://www.embase.com/search/results?subaction=viewrecord&id=L2008437889&from=exporthttp://dx.doi.org/10.1093/cid/ciz685 |en
dc.identifier.risid2718en
dc.description.pages2517-2526en
local.message.claim2024-06-20T09:19:01.204+1000|||rp03979|||submit_approve|||dc_contributor_author|||None*
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.languageiso639-1en-
item.grantfulltextnone-
item.openairetypeArticle-
Appears in Sites:Children's Health Queensland Publications
Show simple item record

Page view(s)

34
checked on Sep 17, 2024

Google ScholarTM

Check

Altmetric


Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.